Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study. (Q51411509)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 November 2009

Language	Label	Description	Also known as
English	Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.	scientific article published on 25 November 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

type 2 diabetes

1 reference

based on heuristic

inferred from title

Riccardo Ientile

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Carlo Bruno Giorda

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Giuseppina Tiziana Russo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Antonino Di Benedetto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Domenico Magazzù

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Annalisa Giandalia

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Marcello Previti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Enrico Di Cesare

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Domenico Cucinotta

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

25 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Acta Diabetologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

95-101

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Homocysteine and cardiovascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Correlates of total homocysteine plasma concentration in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Plasma homocysteine, methylenetetrahydrofolate reductase gene polymorphism and carotid intima-media thickness in Italian type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Homocysteine lowering with folic acid and B vitamins in vascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan

1 reference

https://api.crossref.org/works/10.1007%2FS00592-009-0169-5

21 January 2018

Identifiers

10.1007/S00592-009-0169-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19937354%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51411509&oldid=2210845119"